Alpha Paradigm Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Alpha Paradigm Partners’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,526	Closed	-$324K	–	669
2022 Q2	$324K	Sell	4,526 -4,114	-48%	-$301K	0.13%	252
2022 Q1	$699K	Buy	8,640 +6,355	+278%	+$538K	0.28%	105
2021 Q4	$235K	Buy	+2,285	New	+$219K	0.09%	314
2021 Q3	–	Sell	-468	Closed	-$42K	–	707
2021 Q2	$42K	Buy	+468	New	+$39.5K	0.02%	487

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Alpha Paradigm Partners's SYNH Position: Q3 2022 in Review

Alpha Paradigm Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 4,526 shares — an estimated $324K sold.

Alpha Paradigm Partners first reported a position in SYNH in Q2 2021 and held it in 4 quarters. The position peaked at $699K in Q1 2022. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

Alpha Paradigm Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
Alpha Paradigm Partners sold 4,526 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $324K.
Alpha Paradigm Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2021 and held it in 4 quarters.
Alpha Paradigm Partners's Syneos Health, Inc. Class A Common Stock position peaked at $699K in Q1 2022.
337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on Alpha Paradigm Partners's 13F filing for Q3 2022, filed 15 Nov 2022.